| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 167,2 k € | -12.1% | 190,3 k € | +17.8% | 161,6 k € | -22.3% | 208,0 k € | +112.0% | 98,1 k € | -0.7% | 98,8 k € | +20.1% | 82,2 k € | +31.6% | 62,5 k € | -20.6% | 78,7 k € | +69.8% | 46,4 k € | -56.1% | 105,5 k € | |
| EBITDA | 131,6 k € | -13.7% | 152,5 k € | +15.7% | 131,8 k € | -25.1% | 176,1 k € | +145.3% | 71,8 k € | -1.1% | 72,6 k € | +21.7% | 59,6 k € | +57.2% | 38,0 k € | -34.6% | 58,0 k € | +104.0% | 28,4 k € | -68.9% | 91,3 k € | |
| Operating profit | 113,8 k € | -13.8% | 132,0 k € | +10.9% | 119,1 k € | -29.1% | 168,1 k € | +157.7% | 65,2 k € | +10.1% | 59,3 k € | +33.9% | 44,3 k € | +98.4% | 22,3 k € | -46.9% | 42,0 k € | +226.3% | 12,9 k € | -84.2% | 81,7 k € | |
| Profit/loss | 83,4 k € | -14.0% | 97,0 k € | +7.8% | 89,9 k € | -27.6% | 124,3 k € | +158.1% | 48,1 k € | +10.2% | 43,7 k € | +33.1% | 32,8 k € | +97.1% | 16,6 k € | -40.6% | 28,0 k € | +259.3% | 7,8 k € | -85.4% | 53,4 k € | |
| Equity | 18,6 k € | -83.9% | 115,6 k € | +521.3% | 18,6 k € | -58.4% | 44,7 k € | -40.6% | 75,3 k € | -40.1% | 125,7 k € | -13.3% | 144,9 k € | +29.3% | 112,1 k € | +17.4% | 95,4 k € | +41.6% | 67,4 k € | +13.1% | 59,6 k € | |
| Total assets | 220,0 k € | +0.1% | 219,7 k € | -14.7% | 257,6 k € | +19.8% | 215,0 k € | +64.3% | 130,8 k € | -23.8% | 171,6 k € | -10.8% | 192,4 k € | +15.0% | 167,3 k € | +17.8% | 142,0 k € | -9.6% | 157,2 k € | +62.9% | 96,5 k € | |
| Cash | 149,0 k € | +27.3% | 117,0 k € | -24.6% | 155,3 k € | -10.0% | 172,5 k € | +62.9% | 105,9 k € | -27.9% | 146,8 k € | +84.3% | 79,7 k € | +66.1% | 48,0 k € | -17.7% | 58,3 k € | -22.3% | 75,0 k € | +10.7% | 67,8 k € | |
| Debts | 190,6 k € | +100.9% | 94,9 k € | -60.2% | 238,3 k € | +47.3% | 161,8 k € | +221.3% | 50,4 k € | +26.5% | 39,8 k € | -2.7% | 40,9 k € | -26.0% | 55,2 k € | +18.6% | 46,6 k € | -48.1% | 89,8 k € | +143.5% | 36,9 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 1 | |||||||||||
Private limited company · Woluwe-Saint-Pierre · incorporated on 24/09/2014
Private limited company profitable but thinly capitalised. Cash position rising (+27.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (18,6 k €) relative to earnings. The abridged model hides revenue.
WOLUMED is a Private limited company incorporated in 2014. Its main activity is: General medical practice activities. Its registered office is in Woluwe-Saint-Pierre.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette